Deric Park, MD, FACP
| Board Certified American Board of Psychiatry & Neurology Neuro-Oncology, United Council for Neurologic Subspecialites |
| Associate Professor, Director of Neuro-Oncology Department of Neurology Committee on Clinical Pharmacology and Pharmacogenomics, University of Chicago, Chicago, IL |
| Chief, Section of Neuro-Oncology Department of Neurology, University of Chicago, Chicago, IL |
| Member University of Chicago Comprehensive Cancer Center, University of Chicago, Chicago, IL |
Dr. Deric M. Park is an expert in the diagnosis and treatment of brain and spine tumors, and its complications. In addition to both primary brain and metastatic cancers, he also specializes in rare conditions such as chordoma, meningioma, and hereditary cancer syndromes. He works collaboratively with the patient and family members to develop an individualized approach.
Dr. Park’s research focuses on the development of more effective therapies that will benefit patients suffering from these conditions. His laboratory research efforts have directly been translated to clinical trials and resulted in more than 50 peer-reviewed publications in scientific journals. He has held faculty positions at the University of Pittsburgh Cancer Institute, the University of Virginia, and the National Cancer Institute prior to being recruited to the University of Chicago. He is a recipient of the Merit and Career Development Awards from the American Society of Clinical Oncology, and a member of the Scientific Advisory Board for the Chordoma Foundation.
American Physician
